Helena Motaln

Dr. Helena Motaln


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2010 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ATAnja Torsvik
Anja Torsvik
GRGro Vatne Røsland
Gro Vatne Røsland
ASAgnete Svendsen
Agnete Svendsen
AMAnders Molven
Anders Molven
HIHeike Immervoll
Heike Immervoll
RBRolf Bjerkvig
Rolf Bjerkvig
Although stem cells are critical to tissue repair, several studies indicate that they also may have important roles in malignant transformation and cancer initiation (2–4). Experimental evidence indicates that gastric cancer may originate from bone marrow–derived cells (3), and that osteosarcomas may be derived from MSC (4). Furthermore, several reports show that MSC may support tumor growth and development of metastasis in vivo (5, 6). On the other hand, MSC have also been shown to have tumor suppressor activity. For instance, it has been shown that MSC can inhibit the malignant phenotypes of human liver cancer cell lines, which include proliferation, colony-forming ability, and oncogene expression both in vitro and in vivo (7). A suppressor function of MSC has also been observed for tumor cells of hematopoietic origin (8).

1 August 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RKRok Keber
Rok Keber
HMHelena Motaln
Helena Motaln
KWKay D. Wagner
Kay D. Wagner
Nataša DebeljakNataša Debeljak
Nataša Debeljak
MRMinoo Rassoulzadegan
Minoo Rassoulzadegan
SHSimon Horvat
Simon Horvat
Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. In some ABS patients, reduced activity of the cholesterogenic cytochrome P450 CYP51A1, an ortholog of the mouse CYP51, and accumulation of lanosterol and 24,25-dihydrolanosterol has been reported, but the role of CYP51A1 in the ABS etiology has remained obscure. To test whether Cyp51 could be involved in generating an ABS-like phenotype, a mouse knock-out model was developed that exhibited several prenatal ABS-like features leading to lethality at embryonic day 15. Cyp51(-/-) mice had no functional Cyp51 mRNA and no immunodetectable CYP51 protein. The two CYP51 enzyme substrates (lanosterol and 24,25-dihydrolanosterol) were markedly accumulated. Cholesterol precursors downstream of the CYP51 enzymatic step were not detected, indicating that the targeting in this study blocked de novo cholesterol synthesis. This was reflected in the up-regulation of 10 cholesterol synthesis genes, with the exception of 7-dehydrocholesterol reductase. Lethality was ascribed to heart failure due to hypoplasia, ventricle septum, and epicardial and vasculogenesis defects, suggesting that Cyp51 deficiency was involved in heart development and coronary vessel formation. As the most likely downstream molecular mechanisms, alterations were identified in the sonic hedgehog and retinoic acid signaling pathways. Cyp51 knock-out mice provide evidence that Cyp51 is essential for embryogenesis and present a potential animal model for studying ABS syndrome in humans.

18 March 2010 in Cancer
Verified
Journal Article
Closed access
PDF file
HMHelena Motaln
Helena Motaln
CSCristian Schichor
Cristian Schichor
TLTamara T. Lah
Tamara T. Lah

11 November 2015 in Oncotarget
Verified
Journal Article
Open access
NPNeža Podergajs
Neža Podergajs
HMHelena Motaln
Helena Motaln
URUroš Rajčević
Uroš Rajčević
UVUrška Verbovšek
Urška Verbovšek
MKMarjan Koršič
Marjan Koršič
TTamara Lah
Tamara Lah
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells

9 March 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
Barbara BreznikBarbara Breznik
Barbara Breznik
HMHelena Motaln
Helena Motaln
MVMiloš Vittori
Miloš Vittori
Ana RotterAna Rotter
Ana Rotter
TTamara Lah
Tamara Lah
Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines

20 October 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
HMHelena Motaln
Helena Motaln
AKAna Koren
Ana Koren
KGKristina Gruden
Kristina Gruden
Živa RamšakŽiva Ramšak
Živa Ramšak
CSChristian Schichor
Christian Schichor
TLTamara T. Lah
Tamara T. Lah
Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance